Sepsis-Induced Cardiomyopathy Risk May Extend Even Postdischarge

Sepsis-Induced Cardiomyopathy Risk May Extend Even Postdischarge

Abdullah Hashmi, MD, for Medscape

May 18, 2022

1

The study covered in this summary was published in papers.ssrn.com as a preprint and has not yet been peer reviewed.

Key Takeaways

  • Overall in-hospital mortality for patients with sepsis-induced cardiomyopathy (SIC) trended higher, short of significance, than for patients with sepsis but no related cardiomyopathy in a meta-analysis of studies and systematic review of the literature.

  • But in-hospital mortality for patients with SIC from 10 days after hospitalization to 1 month was significantly increased, as was 1-month mortality.

  • One-month mortality in patients with SIC was more strongly associated with right ventricular (RV) dysfunction than with left ventricular (LV) dysfunction.

Why This Matters

  • The meta-analysis of studies clarifying prognosis after SIC at different hospitalization intervals suggests that the condition can persist as a disease state long after the acute stage, even after discharge, and underscores the importance of extended surveillance and care of such patients.

  • Given the apparent relevance of RV, as well as LV, dysfunction to prognosis in patients with SIC, assessment of bilateral cardiac function is vital to management.

Study Design

  • The authors performed a meta-analysis and provide a systematic review of English-language reports published up to July 2021 and catalogued in Embase and PubMed for which mortality in patients with SIC, as opposed to other issues, such as cardiac function, was a main focus.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....